A. Ruelland
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
- Paraoxonase enzyme and polymorphisms
- Biochemistry top 10%
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Multiple Myeloma Research and Treatments 4
- Blood groups and transfusion 2
- Genetics 5
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- D Maugendre (2 shared papers)H Allannic (2 shared papers)Isabelle Colombet (1 shared paper)Gilles Châtellier (1 shared paper)Patrice Degoulet (1 shared paper)François Gueyffier (1 shared paper)Marie‐Christine Jaulent (1 shared paper)François Paillard (1 shared paper)
In The Last Decade
A. Ruelland
27 papers receiving 461 citations
Peers
Comparison fields: 5 of 92
- Clinical Biochemistry 107
- Biochemistry 43
- Endocrinology, Diabetes and Metabolism 79
- Equine 8
- Health Information Management 21
Countries citing papers authored by A. Ruelland
This map shows the geographic impact of A. Ruelland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ruelland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ruelland more than expected).
Fields of papers citing papers by A. Ruelland
This network shows the impact of papers produced by A. Ruelland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ruelland. The network helps show where A. Ruelland may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Ruelland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 141 | |
| 2 | Models to predict cardiovascular risk: comparison of CART, multilayer perceptron and logistic regression. | 2000 | 68 |
| 3 | Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications. | 2002 | 46 |
| 4 | 1993 | 39 | |
| 5 | Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus. | 1995 | 24 |
| 6 | 1997 | 18 | |
| 7 | 2005 | 16 | |
| 8 | 2006 | 15 | |
| 9 | [Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay]. | 1999 | 15 |
| 10 | 2003 | 13 | |
| 11 | 1990 | 12 | |
| 12 | 1988 | 11 | |
| 13 | Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients. | 2000 | 9 |
| 14 | 1985 | 8 | |
| 15 | 2007 | 8 | |
| 16 | 1995 | 6 | |
| 17 | 2006 | 5 | |
| 18 | 2002 | 5 | |
| 19 | 1990 | 4 | |
| 20 | Transitory deficit in high-density lipoproteins and apolipoprotein A-I. | 1990 | 4 |
About A. Ruelland
A. Ruelland is a scholar working on Hematology, Genetics, Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, having authored 28 papers that have together received 478 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Glycosylation and Glycoproteins Research (2 papers), Blood groups and transfusion (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Clinical Biochemistry (107 citations), Biochemistry (43 citations), Endocrinology, Diabetes and Metabolism (79 citations), Equine (8 citations) and Health Information Management (21 citations). A. Ruelland has collaborated with scholars based in France, Belgium and Canada. Frequent co-authors include D Maugendre, H Allannic, Isabelle Colombet, Gilles Châtellier, Patrice Degoulet, François Gueyffier, Marie‐Christine Jaulent, François Paillard, B. Grosbois and Julie Ménard. Their work appears in journals such as Clinica Chimica Acta, Prenatal Diagnosis, Nutrition Metabolism and Cardiovascular Diseases, Equine Veterinary Journal and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.